Free Trial
→ JD Vance Predicts: Wall Street vs. Trump & Your Money (From Priority Gold) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 13 of 15

Slide 13
Back to 12
Continue to 14
 
Back to 12
Continue to 14
 

Avidity Biosciences (NASDAQ:RNA)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
10 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$63.60 (46.8% Upside)

About Avidity Biosciences

Avidity Biosciences logoAvidity Biosciences, Inc, a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/26/2024Royal Bank of CanadaInitiated CoverageOutperform$67.00
11/13/2024Chardan CapitalReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00
11/13/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
10/31/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
10/30/2024Chardan CapitalBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.00
10/21/2024TD CowenBoost Price TargetBuy ➝ Buy$56.00 ➝ $78.00
9/24/2024The Goldman Sachs GroupInitiated CoverageBuy$59.00
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$96.00 ➝ $96.00
9/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$96.00 ➝ $96.00
8/28/2024BarclaysInitiated CoverageOverweight$63.00
Slide 13
Back to 12
Continue to 14
 

Is Your 401(k) Safe? The Real Risk No One Sees Coming (Ad)

Every day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopping, and the digital dollar is coming. You can protect yourself—but only if you act now. Don't wake up too late. Get your Digital Dollar Protection today and secure your retirement before the window closes.

Click Here For Your Free Guide

More From MarketBeat
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Almost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...
MarketBeat
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Top Ten Brokerages You Can Trust
There are more than 500 brokerages and research houses that hire analysts to issue ratings and recommendations...
MarketBeat
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Behind the Markets | Sponsored
7 Low Beta Stocks for the Risk-Averse Investor
Investing is about balancing risk and reward. That's why regardless of market conditions, many investors with ...
MarketBeat